Hospital-based Epidemiological Study on the Distribution of Human Papillomavirus (HPV) Types in Adult Women Diagnosed With Invasive Cervical Cancer (ICC) in New Zealand
- A female aged 18 years and above at the time of cervical specimen collection, and
currently residing in New Zealand.
- Histological diagnoses of invasive cervical cancer stage IB or greater, within at
least the last 3 years.
- Written informed consent obtained from the subject/ next of kin/ Legally acceptable
- Availability of cervical specimen on which the diagnosis was made prior to any
chemotherapy or radiotherapy.
- The cervical specimen should be of appropriate size and with regular tissue
- The cervical specimen should be adequately preserved.
- All links to the subject's identity should be removed from the paraffin block.
Type of Study:
Observational Model: Case-Only, Time Perspective: Retrospective
Occurrence of HPV-16 and HPV-18 in women with invasive cervical cancer
Outcome Time Frame:
At least the last 3 years from the time of study start
GSK Clinical Trials
New Zealand: Medsafe
- Cervical Cancer
- Invasive cervical cancer
- Human papillomavirus
- Uterine Cervical Neoplasms